Tilray Medical, a Tilray Brands subsidiary, has been approved to supply Portugal’s first medical cannabis extract. The product, known as Tilray Oral Solution (THC 5, CBD 20), will be available in late spring for use in “several critical areas of patient care.”
(Source: Tilray Brands)
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Top Story: Who owns Phyto Extractions in 2024?
2 | Xebra Brands (CSE:XBRA) has revealed a manufacturing non-exclusive agreement with KannaGroup to bring premium CBD products to Mexico
3 | Curaleaf International (TSX:CURA) expands into the Czech Republic
Top Cannabis Stocks March 8 to March 14, 2024
1. T.TLRY | 16,426 views | Tilray Brands Inc.
2. T.WEED | 10,937 views | Canopy Growth Corp.
3.T.LABS | 4,721 views | Medipharm Labs Corp.
4. T.CURA | 4,586 views | Curaleaf Holdings Inc.
5. C.OILS | 2,143 views | Nextleaf Solutions Inc.
6.T.CBA| 1,331 views | Aurora Cannabis Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.